Literature DB >> 30367364

Identification of Potential miRNAs Biomarkers for High-Grade Prostate Cancer by Integrated Bioinformatics Analysis.

Laura Foj1, Xavier Filella2.   

Abstract

The increasing number of datasets available in the GEO database offers a new approach to identify new miRNAs related to PCa. The aim of our study was to suggest a miRNA signature for the detection of high-grade PCa (Gleason score ≥ 7) using bioinformatics tools. Three mRNA datasets (GSE26022, GSE30521, GSE46602) were selected to identify the differentially expressed genes (DEGs) in high-grade PCa. Furthermore, two miRNA datasets (GSE45604, GSE46738) were analyzed to select the differentially expressed miRNAs (DEMs). Functional and pathway enrichment analysis was performed using DAVID and a protein-protein interaction network (PPI) was constructed through STRING. Besides, miRNAs which regulate hub genes were predicted using microRNA.org . A total of 973 DEGs were identified after the analyses of the mRNA datasets, enriched in key mechanisms underlying PCa development. Furthermore, we identified 10 hub genes (EGFR, VEGFA, IGF1, PIK3R1, CD44, ITGB4, ANXA1, BCL2, LPAR3, LPAR1). The most significant KEGG Pathway was PI3K-Akt signaling pathway, involved in cell proliferation and survival. Moreover, we identified 30 common miRNAs between significant DEMs and the predicted hub gene regulators. Twelve of these miRNAs (miR-1, -365, -132, -195, -133a, -133b, -200c, -339, -222, -21, -221, -708) regulate two or more hub genes identified in our study. We suggested a signature including these 12 miRNAs for high-grade PCa detection. These miRNAs have been associated with aggressive PCa, poor survival and resistance to treatment in the last years.

Entities:  

Keywords:  Bioinformatics analysis; Differentially expressed genes; Prostate cancer; Protein–protein interaction network; miRNAs

Mesh:

Substances:

Year:  2018        PMID: 30367364     DOI: 10.1007/s12253-018-0508-3

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  49 in total

Review 1.  The KEGG database.

Authors:  Minoru Kanehisa
Journal:  Novartis Found Symp       Date:  2002

2.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.

Authors:  Da Wei Huang; Brad T Sherman; Richard A Lempicki
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

3.  Phosphoinositide 3-kinase pathway activation in phosphate and tensin homolog (PTEN)-deficient prostate cancer cells is independent of receptor tyrosine kinases and mediated by the p110beta and p110delta catalytic subunits.

Authors:  Xinnong Jiang; Sen Chen; John M Asara; Steven P Balk
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

4.  EGF Receptor Promotes Prostate Cancer Bone Metastasis by Downregulating miR-1 and Activating TWIST1.

Authors:  Yung-Sheng Chang; Wei-Yu Chen; Juan Juan Yin; Heather Sheppard-Tillman; Jiaoti Huang; Yen-Nien Liu
Journal:  Cancer Res       Date:  2015-06-12       Impact factor: 12.701

5.  PTEN loss in biopsy tissue predicts poor clinical outcomes in prostate cancer.

Authors:  Prabhakar Mithal; Emma Allott; Leah Gerber; Julia Reid; William Welbourn; Eliso Tikishvili; Jimmy Park; Adib Younus; Zaina Sangale; Jerry S Lanchbury; Steven Stone; Stephen J Freedland
Journal:  Int J Urol       Date:  2014-08-05       Impact factor: 3.369

6.  Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer.

Authors:  Stefan Ambs; Robyn L Prueitt; Ming Yi; Robert S Hudson; Tiffany M Howe; Fabio Petrocca; Tiffany A Wallace; Chang-Gong Liu; Stefano Volinia; George A Calin; Harris G Yfantis; Robert M Stephens; Carlo M Croce
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

7.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

8.  miR-21: an oncomir on strike in prostate cancer.

Authors:  Marco Folini; Paolo Gandellini; Nicole Longoni; Valentina Profumo; Maurizio Callari; Marzia Pennati; Maurizio Colecchia; Rosanna Supino; Silvia Veneroni; Roberto Salvioni; Riccardo Valdagni; Maria Grazia Daidone; Nadia Zaffaroni
Journal:  Mol Cancer       Date:  2010-01-21       Impact factor: 27.401

9.  Regulation of epidermal growth factor receptor signaling and erlotinib sensitivity in head and neck cancer cells by miR-7.

Authors:  Felicity C Kalinowski; Keith M Giles; Patrick A Candy; Alishum Ali; Clarissa Ganda; Michael R Epis; Rebecca J Webster; Peter J Leedman
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

10.  Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy.

Authors:  Martin Mørck Mortensen; Søren Høyer; Anne-Sophie Lynnerup; Torben Falck Ørntoft; Karina Dalsgaard Sørensen; Michael Borre; Lars Dyrskjøt
Journal:  Sci Rep       Date:  2015-11-02       Impact factor: 4.379

View more
  3 in total

1.  Screening a novel six critical gene-based system of diagnostic and prognostic biomarkers in prostate adenocarcinoma patients with different clinical variables.

Authors:  Hadia Munir; Fawad Ahmad; Sajid Ullah; Saeedah Musaed Almutairi; Samra Asghar; Tehmina Siddique; Mostafa A Abdel-Maksoud; Rabab Ahmed Rasheed; Fatma Alzahraa A Elkhamisy; Mohammed Aufy; Hamid Yaz
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

2.  Silybin Prevents Prostate Cancer by Inhibited the ALDH1A1 Expression in the Retinol Metabolism Pathway.

Authors:  Ying Jiang; Hanbing Song; Ling Jiang; Yu Qiao; Dan Yang; Donghua Wang; Ji Li
Journal:  Front Cell Dev Biol       Date:  2020-08-31

Review 3.  Data-driven translational prostate cancer research: from biomarker discovery to clinical decision.

Authors:  Yuxin Lin; Xiaojun Zhao; Zhijun Miao; Zhixin Ling; Xuedong Wei; Jinxian Pu; Jianquan Hou; Bairong Shen
Journal:  J Transl Med       Date:  2020-03-07       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.